Your browser doesn't support javascript.
loading
Vaccine-elicited antibody that neutralizes H5N1 influenza and variants binds the receptor site and polymorphic sites.
Winarski, Katie L; Thornburg, Natalie J; Yu, Yingchun; Sapparapu, Gopal; Crowe, James E; Spiller, Benjamin W.
Affiliation
  • Winarski KL; Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232;
  • Thornburg NJ; Vanderbilt Vaccine Center, Vanderbilt University School of Medicine, Nashville, TN 37232;
  • Yu Y; Vanderbilt Vaccine Center, Vanderbilt University School of Medicine, Nashville, TN 37232;
  • Sapparapu G; Vanderbilt Vaccine Center, Vanderbilt University School of Medicine, Nashville, TN 37232;
  • Crowe JE; Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232; Vanderbilt Vaccine Center, Vanderbilt University School of Medicine, Nashville, TN 37232;
  • Spiller BW; Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232; Department of Pharmacology and Center for Structural Biology, Vanderbilt University School of Medicine, Nashville, TN 37232 benjamin.spiller@vanderbilt.edu.
Proc Natl Acad Sci U S A ; 112(30): 9346-51, 2015 Jul 28.
Article in En | MEDLINE | ID: mdl-26170302

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Influenza Vaccines / Hemagglutinin Glycoproteins, Influenza Virus / Influenza A Virus, H5N1 Subtype / Antibodies, Viral Limits: Humans Language: En Journal: Proc Natl Acad Sci U S A Year: 2015 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Influenza Vaccines / Hemagglutinin Glycoproteins, Influenza Virus / Influenza A Virus, H5N1 Subtype / Antibodies, Viral Limits: Humans Language: En Journal: Proc Natl Acad Sci U S A Year: 2015 Document type: Article Country of publication: United States